While 15 million people worldwide suffer a stroke each year, the only pharmacological therapy available for stroke patients—the clot-busting agent, tissue plasminogen activator (t-PA)–must be administered strictly within a 4.5 h window from the time of stroke onset. This evidence concerns the gene PLAT and stroke disorder.